Eijiro Omoto

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano et al. · PubMed · 1999 · 765 citations

Medicine, Genetics, Oncology +16

Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)

Yoshinobu Matsuo, RAF MacLeod, CC Uphoff et al. · Leukemia · 1997 · 227 citations

Life Sciences, Hematology, Molecular Genetics +16

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.

Norio Asou, Koichi Adachi, Jun‐ichi Tamura et al. · Journal of Clinical Oncology · 1998 · 208 citations

Medicine, Oncology, Pharmacotherapy +14

The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells

Yoshio Katayama, Tomonori Yano, Akihiro Bessho et al. · Bone Marrow Transplantation · 1997 · 95 citations

Life Sciences, Cell Biology, Hematology +13

No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.

Shuichi Miyawaki, M Tanimoto, T Kobayashi et al. · PubMed · 1999 · 67 citations

Medicine, Hematology, Oncology +14